August 28, 2014 9:43 AM ET

Pharmaceuticals

Company Overview of BioSante Pharmaceuticals, Inc.

Executive Profile

Ross J. Mangano

Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee, ANI Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
68$150,581

Background

Mr. Ross J. Mangano has been the President of Oliver Land Corporation since 1992 and Oliver Estate, Inc. since 1996. Mr. Mangano serves as an Investment Analyst for Oliver Estate, Inc. Prior to that, he served in various management positions with Oliver Estate, Inc., since 1971. Mr. Mangano has been the Chairman of the Board of U.S RealTel, Inc. since February 2002 and Antares WELLS-CTI, Inc. since February 1993. He has been the Chairman of Cerprobe Corporation since ...

Corporate Headquarters

111 Barclay Boulevard
Lincolnshire, Illinois 60069

United States

Phone: 847-478-0500
Fax: 847-478-9152

Board Members Memberships

Former Director
1988-Present
Chairman of the Board
1993-Present
Director
1998-N/A
Former Chairman of the Board, Member of Audit Committee, Member of Compensation Committee, Member of Nominating Committee, Chairman of the Board of Cypress Communications and Director of Cypress Communications
1999-N/A
Director, Member of Audit & Finance Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2013-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$54,489
Total Calculated Compensation$150,581
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Glenn Mario Saldanha Chairman of The Board, Managing Director, Chief Executive Officer, Member of Shareholders/Investors Grievance Committee and Member of Nomination & Remuneration Committee
Glenmark Pharmaceuticals Ltd.
$57.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioSante Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.